arrow_back Back Filing freshness 10-K Q4 FY2026 SEC EDGAR

MCKESSON CORP

MCK
$869.27 ▼ -1.46 (-0.17%) at close
Healthcare ·Wholesale-Drugs, Proprietaries & Druggists' Sundries ·USWholesale-Drugs, Proprietaries & Druggists' Sundries
74 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
42
Health
Weak
Moderately Bearish
auto_awesome

Analytical Summary

MCKESSON CORP faces fundamental challenges with weakness in Return on Common Equity (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap
Dividend Yield 0.09%
Revenue Growth 6.0%
Op. Margin 2.2%
ROIC 43.1%
FCF / Share None
Trailing P/E 63.4x
Price / Book
FCF Yield
Debt / Equity -3.00
info Valuation on last close. End-of-day price, Aug 7, 2026.

74-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$96.30B
↑ +6.0%
Net Income Profit after all expenses
$1.68B
↑ +33.5%
Operating Margin Operating profit as % of sales
2.2%
↑ +46.4% 34th
FCF / Share Free cash flow per share
$9.12
↓ -51.1%
Long-Term Debt Long-term obligations
$6.53B
— -0.5%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
31
Returns
1
Financial Health
95
Cash Quality
66

Dividend History

Dividend / share · sourced from SEC filings
$3.17 Latest / share
+15.3% YoY
+11.5% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 20 years · 74 quarters